N
Natixis Portfolio holdings
AUM
$20.1B
1-Year Return
17.51%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Quarter Return
+15.58%
1 Year Return
+17.51%
3 Year Return
+106.1%
5 Year Return
+162.29%
10 Year Return
+380.38%
AUM
$18B
AUM Growth
+$4.78B
(+36%)
Cap. Flow
+$3.26B
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
39.42%
Holding
1,254
New
248
Increased
345
Reduced
296
Closed
273
Top Buys
| 1 |
Microsoft
MSFT
|
+$563M |
| 2 |
Apple
AAPL
|
+$463M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$442M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$315M |
| 5 |
NVIDIA
NVDA
|
+$262M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$663M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$104M |
| 3 |
Prologis
PLD
|
+$102M |
| 4 |
Cigna
CI
|
+$90.1M |
| 5 |
Procter & Gamble
PG
|
+$82.8M |
Sector Composition
| 1 | Technology | 38.81% |
| 2 | Consumer Discretionary | 10.31% |
| 3 | Financials | 9.02% |
| 4 | Healthcare | 7.94% |
| 5 | Communication Services | 4.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Alcoa
AA
$8.16B
| $434K | ﹤0.01% |
12,852
+4,610
| +56% | +$156K |
|
627
Entrada Therapeutics
TRDA
$200M
| $433K | ﹤0.01% |
31,186
| – | – |
|
628
TAL Education Group
TAL
$6.33B
| $418K | ﹤0.01% |
+36,811
| New | +$418K |
|
629
Dyne Therapeutics
DYN
$1.87B
| $397K | ﹤0.01% |
14,000
-26,000
| -65% | -$738K |
|
|
RVNC
630
DELISTED
Revance Therapeutics, Inc.
RVNC
| $391K | ﹤0.01% |
+79,457
| New | +$391K |
|
631
Blackrock
BLK
$171B
| $390K | ﹤0.01% |
+468
| New | +$390K |
|
632
ADT
ADT
$7.04B
| $385K | ﹤0.01% |
+57,289
| New | +$385K |
|
633
Robinhood
HOOD
$107B
| $378K | ﹤0.01% |
+18,784
| New | +$378K |
|
634
iShares Semiconductor ETF
SOXX
$13.9B
| $361K | ﹤0.01% |
+1,600
| New | +$361K |
|
635
Waste Connections
WCN
$45.3B
| $360K | ﹤0.01% |
+2,093
| New | +$360K |
|
636
Moelis & Co
MC
$5.34B
| $358K | ﹤0.01% |
6,300
-9,300
| -60% | -$528K |
|
637
iShares MSCI Emerging Markets Asia ETF
EEMA
$1.47B
| $349K | ﹤0.01% |
+5,100
| New | +$349K |
|
638
iShares Currency Hedged MSCI Japan ETF
HEWJ
$391M
| $349K | ﹤0.01% |
+8,304
| New | +$349K |
|
639
Cintas
CTAS
$81.3B
| $346K | ﹤0.01% |
+2,012
| New | +$346K |
|
640
Delta Air Lines
DAL
$40B
| $338K | ﹤0.01% |
7,071
-122,234
| -95% | -$5.85M |
|
641
Q2 Holdings
QTWO
$5.18B
| $336K | ﹤0.01% |
+6,385
| New | +$336K |
|
642
Intapp
INTA
$3.62B
| $333K | ﹤0.01% |
9,785
+1,421
| +17% | +$48.4K |
|
643
Viatris
VTRS
$12B
| $329K | ﹤0.01% |
+27,562
| New | +$329K |
|
644
Okta
OKTA
$16.1B
| $323K | ﹤0.01% |
3,088
-1,500
| -33% | -$157K |
|
645
MSC Industrial Direct
MSM
$5.09B
| $320K | ﹤0.01% |
+3,300
| New | +$320K |
|
646
Union Pacific
UNP
$125B
| $320K | ﹤0.01% |
1,300
-66,679
| -98% | -$16.4M |
|
647
Elanco Animal Health
ELAN
$9.38B
| $319K | ﹤0.01% |
19,573
-439
| -2% | -$7.15K |
|
648
Rocket Lab Corporation Common Stock
RKLB
$22.6B
| $310K | ﹤0.01% |
75,479
-632
| -0.8% | -$2.6K |
|
649
Valmont Industries
VMI
$7.46B
| $306K | ﹤0.01% |
1,342
-272
| -17% | -$62.1K |
|
650
Cooper Companies
COO
$13.4B
| $303K | ﹤0.01% |
2,988
-14,748
| -83% | -$1.5M |
|